LifeMine Therapeutics Inc.: LifeMine Therapeutics Expands Management Team with Appointments of Martin Stahl, Ph.D., as Chief Scientific Officer and Louis Plamondon, Ph.D., as Executive Vice President and Head of CMC

LifeMine Therapeutics Inc., a biopharmaceutical company reinventing drug discovery by mininggenetically-encoded small molecules (GEMs) from the biosphere, today announced the appointments of Martin Stahl

Related Keywords

Germany ,Cambridge ,Cambridgeshire ,United Kingdom ,Switzerland ,Louis Plamondon ,Kostenloser Wertpapierhandel ,Gregory Verdine ,Katie Engleman ,Weiqing Zhou ,Martin Stahl ,Richard Klausner ,University Of Freiburg ,Lifemine Therapeutics Inc ,Cambridge Crystallographic Data Centre ,Harvard University ,Philipp University Of Marburg ,Constellation Pharmaceuticalsa Morphosys ,Julius Maximilians University ,National Award For Computers ,Medicinal Chemistry ,Cambridge Crystallographic Data ,Philipp University ,Constellation Pharmaceuticals ,Mine Therapeutics ,Gloucester Harbor ,Lifemine ,Herapeutics ,Xpands ,Management ,Team ,Appointments ,Martin ,Stahl ,Chief ,Cientific ,Officer ,Louis ,Lamondon ,Executive ,Ice ,President ,Head ,